The purpose of this study is to determine whether Hizentra is a safe and effective treatment for people with myasthenia gravis (MG).
Sponsor: Mazen Dimachkie, MD
Year MSG Membership Ends: 2022
Link: https://clinicaltrials.gov/ct2/show/NCT02100969Year Trial Ends: 2017